Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 9 studies | 34% ± 16% | |
basal cell | 6 studies | 31% ± 24% | |
epithelial cell | 5 studies | 35% ± 14% | |
cardiac muscle cell | 5 studies | 25% ± 2% | |
Mueller cell | 5 studies | 43% ± 14% | |
adipocyte | 5 studies | 24% ± 3% | |
GABAergic neuron | 5 studies | 40% ± 18% | |
endothelial cell | 4 studies | 24% ± 8% | |
ciliated cell | 4 studies | 23% ± 3% | |
glutamatergic neuron | 4 studies | 49% ± 18% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 7% | |
interneuron | 4 studies | 40% ± 21% | |
oligodendrocyte | 4 studies | 22% ± 5% | |
neuron | 3 studies | 22% ± 8% | |
hepatocyte | 3 studies | 42% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6055.21 | 1445 / 1445 | 100% | 22.72 | 183 / 183 |
prostate | 100% | 2282.63 | 245 / 245 | 100% | 20.23 | 501 / 502 |
thymus | 100% | 2142.23 | 653 / 653 | 99% | 12.90 | 599 / 605 |
breast | 100% | 2090.96 | 458 / 459 | 99% | 37.76 | 1104 / 1118 |
bladder | 100% | 2703.00 | 21 / 21 | 98% | 13.51 | 495 / 504 |
uterus | 99% | 2027.12 | 169 / 170 | 99% | 19.99 | 453 / 459 |
kidney | 99% | 1461.25 | 88 / 89 | 99% | 15.56 | 890 / 901 |
intestine | 100% | 2790.29 | 966 / 966 | 97% | 11.27 | 510 / 527 |
brain | 97% | 1670.91 | 2555 / 2642 | 100% | 12.44 | 702 / 705 |
stomach | 99% | 1859.79 | 356 / 359 | 97% | 12.86 | 277 / 286 |
ovary | 99% | 1463.30 | 178 / 180 | 97% | 8.23 | 416 / 430 |
liver | 100% | 3587.92 | 226 / 226 | 95% | 11.27 | 386 / 406 |
lung | 95% | 1349.10 | 548 / 578 | 100% | 16.29 | 1153 / 1155 |
adrenal gland | 100% | 2007.00 | 257 / 258 | 90% | 6.67 | 207 / 230 |
skin | 99% | 1537.07 | 1786 / 1809 | 87% | 10.27 | 409 / 472 |
pancreas | 86% | 778.96 | 282 / 328 | 97% | 9.92 | 173 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.40 | 29 / 29 |
muscle | 100% | 19394.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1753.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.23 | 1 / 1 |
blood vessel | 100% | 2679.31 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2087.56 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 94% | 3361.71 | 812 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 46% | 3.58 | 37 / 80 |
peripheral blood | 37% | 961.49 | 344 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0005980 | Biological process | glycogen catabolic process |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0005576 | Cellular component | extracellular region |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0016234 | Cellular component | inclusion body |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0043033 | Cellular component | isoamylase complex |
GO_0005634 | Cellular component | nucleus |
GO_0004133 | Molecular function | glycogen debranching enzyme activity |
GO_0102500 | Molecular function | beta-maltose 4-alpha-glucanotransferase activity |
GO_0030247 | Molecular function | polysaccharide binding |
GO_0004135 | Molecular function | amylo-alpha-1,6-glucosidase activity |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0004134 | Molecular function | 4-alpha-glucanotransferase activity |
Gene name | AGL |
Protein name | Glycogen debranching enzyme (EC 2.4.1.25) (EC 3.2.1.33) (Glycogen debrancher) Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)] Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
Synonyms | hCG_31497 GDE |
Description | FUNCTION: Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation. FUNCTION: Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation. . FUNCTION: Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation. . FUNCTION: Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation. . |
Accessions | ENST00000370165.7 [P35573-1] ENST00000294724.8 [P35573-1] P35573 A0A1C7CYW1 G1UI17 ENST00000370161.6 [P35573-3] ENST00000361915.8 [P35573-1] ENST00000361302.7 ENST00000370163.7 [P35573-1] A0A0M4G3H8 A0A0S2A4E4 |